Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.33 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.32 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3384132 | 0.68 | UGT2B7 (0.53) | UGT2B7 | |
| SCHEMBL28161277 | 0.68 | LMNA (0.36) | UGT2B7SLC6A12SLC6A11 | |
| SCHEMBL28161233 | 0.68 | LMNA (0.36) | UGT2B7SLC6A12SLC6A11 | |
| SCHEMBL27764954 | 0.64 | EPHX1 (0.31) | — | |
| SCHEMBL10776004 | 0.64 | UGT2B7 (0.35) | UGT2B7 | |
| SCHEMBL10776006 | 0.64 | UGT2B7 (0.35) | UGT2B7 | |
| SCHEMBL16638026 | 0.63 | KDM4E (0.32) | — | |
| SCHEMBL3986262 | 0.63 | UGT2B7 (0.40) | UGT2B7 | |
| SCHEMBL28160745 | 0.61 | LMNA (0.33) | UGT2B7SLC6A12SLC6A11 | |
| SCHEMBL28161234 | 0.61 | LMNA (0.33) | UGT2B7SLC6A12SLC6A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200054057-A1 | USE OF ACETYLENIC FATTY ACID COMPOUNDS AS KOKUMI FLAVOR | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2020-02-20 | — | — | US | disclosed |
| WO-2018202862-A1 | USE OF ACETYLENIC FATTY ACID COMPOUNDS AS KOKUMI FLAVOR | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-11-08 | — | — | WO | disclosed |
| EP-3398442-A1 | USE OF ACETYLENIC FATTY ACID COMPOUNDS AS KOKUMI FLAVOR | Takasago International Corporation (JP) | 2018-11-07 | — | — | EP | disclosed |
| US-9894921-B2 | Use of cinnamic acid derivatives containing nitrogen as flavouring agents | SYMRISE AG (DE) | 2018-02-20 | — | — | US | disclosed |
| US-20150272185-A1 | USE OF CINNAMIC ACID DERIVATIVES CONTAINING NITROGEN AS FLAVOURING AGENTS | SYMRISE AG (DE) | 2015-10-01 | — | — | US | disclosed |
| US-9144248-B2 | Cinnamamides as savory flavorings | SYMRISE AG (DE) | 2015-09-29 | — | — | US | disclosed |
| US-8871288-B2 | Aromatic neomenthylamides as flavoring substances | SYMRISE AG (DE) | 2014-10-28 | — | — | US | disclosed |
| US-8852664-B2 | Neo-menthyl derivatives as flavor materials | SYMRISE AG (DE) | 2014-10-07 | — | — | US | disclosed |
| US-8487133-B2 | Substituted bicyclo [4.1.0] heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances | SYMRISE AG (DE) | 2013-07-16 | — | — | US | disclosed |
| US-20130178534-A1 | N-Nonanoylvanillylamine as an agent for reducing the appetite, as an agent for imparting a feeling of fullness and as a mood enhancer, and corresponding substance mixtures, orally consumable products and methods | SYMRISE AG (DE) | 2013-07-11 | — | — | US | disclosed |
| US-8309158-B2 | Composition for reducing the NaCl content in food products | SYMRISE AG (DE) | 2012-11-13 | — | — | US | disclosed |
| US-8273398-B2 | Geranylamine derivates of oxalic acid | SYMRISE AG (DE) | 2012-09-25 | — | — | US | disclosed |
| US-20100189863-A1 | SUBSTITUTED BICYCLO [4.1.0] HEPTANE-7-CARBOXYLIC ACID AMIDES AND DERIVATIVES THEREOF AS FOOD FLAVOR SUBSTANCES | SYMRISE GMBH & CO.KG (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100080880-A1 | GERANYLAMINE DERIVATES OF OXALIC ACID | SYMRISE GMBH & CO. KG (DE) | 2010-04-01 | — | — | US | disclosed |
| US-20100028496-A1 | Composition for reducing the NaCl content in food products | SYMRISE GMBH & CO. KG (DE) | 2010-02-04 | — | — | US | disclosed |
| US-20090311401-A1 | Neo-Menthyl Derivatives as Flavor Materials | SYMRISE GMBH & CO. KG (DE) | 2009-12-17 | — | — | US | disclosed |
| CN-101528060-A | Substituted bicyclo[4.1.0]heptane-7-carboxylic acid amides and derivatives thereof as food flavor substances | SYMRISE GMBH & CO KG (DE) | 2009-09-09 | — | — | CN | disclosed |
| EP-2079322-A1 | SUBSTITUTED BICYCLOÝ4.1.0¨HEPTANE-7-CARBOXYLIC ACID AMIDES AND DERIVATIVES THEREOF AS FOOD FLAVOR SUBSTANCES | Symrise GmbH & Co. KG (DE) | 2009-07-22 | — | — | EP | disclosed |
| US-20090110796-A1 | AROMATIC NEOMENTHYLAMIDES AS FLAVORING SUBSTANCES | SYMRISE GMBH & CO. KG (DE) | 2009-04-30 | — | — | US | disclosed |
| WO-2008046895-A1 | SUBSTITUTED BICYCLO[4.1.0]HEPTANE-7-CARBOXYLIC ACID AMIDES AND DERIVATIVES THEREOF AS FOOD FLAVOR SUBSTANCES | SYMRISE GMBH & CO. KG (DE) | 2008-04-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100189863-A1 | SUBSTITUTED BICYCLO [4.1.0] HEPTANE-7-CARBOXYLIC ACID AMIDES AND DERIVATIVES THEREOF AS FOOD FLAVOR SUBSTANCES | HCAR3, TAS2R1, HCAR1 | UGT2B7 1303/4885SLC6A12 2424/4885SLC6A11 1932/4885 |
| US-20090110796-A1 | AROMATIC NEOMENTHYLAMIDES AS FLAVORING SUBSTANCES | AOC3, NPR3, AOC2 | UGT2B7 1062/4885SLC6A12 1159/4885SLC6A11 787/4885 |
| US-20100080880-A1 | GERANYLAMINE DERIVATES OF OXALIC ACID | OTC, OAT, ODC1 | UGT2B7 213/4885SLC6A12 414/4885SLC6A11 1581/4885 |
| US-20130178534-A1 | N-Nonanoylvanillylamine as an agent for reducing the appetite, as an agent for imparting a feeling of fullness and as a mood enhancer, and corresponding substance mixtures, orally consumable products and methods | MC4R, PNMT, AANAT | UGT2B7 2410/4885SLC6A12 599/4885SLC6A11 473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.